December 26, 2012 — Covidien announced a definitive agreement to acquire CV Ingenuity. The companies expect to complete the acquisition in the first calendar quarter of 2013. Financial terms of the transaction were not disclosed. CV Ingenuity, a privately held company based in Fremont, Calif., is focused on improving patient outcomes in the treatment of peripheral arterial disease (PAD).
